CompaniesByCap
ZVRA
Zevra Therapeutics, Inc. (ZVRA)
NASDAQ · Healthcare

Zevra Therapeutics, Inc. Cash Flow 2013–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Operating Activities
Operating Cash Flow-1.6M-69.7M-33.5M-18.7M10.4M-1.9M-23.7M-54.2M-33.1M-29.8M-20.3M
Depreciation & Amort.
Investing Activities
Capital Expenditure835,0000296,00093,000102,00033,00026,00021,000181,000643,000135,000
Free Cash Flow-2.4M-69.7M-33.8M-18.8M10.3M-2.0M-23.8M-54.2M-33.3M-30.4M-20.4M
Financing Activities
Dividends Paid
Stock Buybacks03.4M4.7M2.8M0

Zevra Therapeutics, Inc. Cash Flow — FAQ

Zevra Therapeutics, Inc. (ZVRA) cash flow over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ZVRA's cash flow history?

The chart and table above show Zevra Therapeutics, Inc.'s cash flow by year and by quarter, including the growth rate.